CALL US: 1-855-483-4325

CTLA4-lg (Abatacept) for the Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At-Risk for Type 1 Diabetes

Purpose

The goal of this study is to learn if the drug Abatacept will help delay or prevent the onset of abnormal glucose levels and/ or the onset of type 1 diabetes by delaying or preventing beta cell destruction. For more informatin about this study, contact Roberta Cook by phone at 352-294-5759 or email cookrb@peds.ufl.edu

Keywords

type 1 diabetes, trialnet, prevention

Principal Investigator

Desmond Schatz, M.D.

Department

PEDIATRICS

Contact Information

schatz@ufl.edu
(352) 334-1390

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams